Cryptogenic stroke and patent foramen ovale
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The
dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of …
dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of …
Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis
S De Rosa, H Sievert, J Sabatino… - Annals of internal …, 2018 - acpjournals.org
Background: New evidence emerged recently regarding the percutaneous closure of patent
foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose …
foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose …
Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects
Objectives To perform an updated meta-analysis to evaluate the long-term cardiovascular
and cerebrovascular outcomes among migraineurs. Setting A meta-analysis of cohort …
and cerebrovascular outcomes among migraineurs. Setting A meta-analysis of cohort …
Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials
Aims The efficacy of patent foramen ovale (PFO) closure for cryptogenic stroke has been
controversial. We undertook a meta-analysis of randomized controlled trials (RCTs) …
controversial. We undertook a meta-analysis of randomized controlled trials (RCTs) …
SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American …
Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary
prevention of recurrent stroke has been controversial. Publication of high‐quality evidence …
prevention of recurrent stroke has been controversial. Publication of high‐quality evidence …
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network …
Objective To examine the relative impact of three management options in patients aged< 60
years with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus …
years with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus …
Patent foramen ovale and hypoxemia
Patent foramen ovale (PFO), an embryonic remnant of the fetal circulation, is present in 20–
25% of adults. Although recent observational studies and clinical trials have established the …
25% of adults. Although recent observational studies and clinical trials have established the …
Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale
Multiple randomized clinical trials have demonstrated the benefit of patent foramen ovale
closure over medical therapy alone for patients who have had a stroke that has been …
closure over medical therapy alone for patients who have had a stroke that has been …
Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism
J Wintzer-Wehekind, A Alperi, C Houde, JM Côté… - Journal of the American …, 2019 - jacc.org
Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …
[HTML][HTML] New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials
Methods Electronic databases were searched for randomised trials that compared
percutaneous PFO closure versus control for patients with cryptogenic stroke or migraine …
percutaneous PFO closure versus control for patients with cryptogenic stroke or migraine …